Charles Ryhee
Stock Analyst at TD Cowen
(1.85)
# 3,037
Out of 4,846 analysts
25
Total ratings
47.62%
Success rate
-0.1%
Average return
Main Sectors:
Stocks Rated by Charles Ryhee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CVS CVS Health | Maintains: Buy | $73 → $80 | $64.04 | +24.92% | 5 | Nov 25, 2024 | |
| WBA Walgreens Boots Alliance | Maintains: Buy | $16 → $14 | $11.25 | +24.44% | 6 | Oct 22, 2024 | |
| MCK McKesson | Maintains: Buy | $563 → $652 | $719.51 | -9.38% | 4 | May 8, 2024 | |
| CVX Chevron | Maintains: Outperform | $185 → $170 | $136.70 | +24.36% | 3 | Feb 24, 2023 | |
| EVH Evolent Health | Maintains: Outperform | $57 → $59 | $7.45 | +691.95% | 2 | Jan 30, 2023 | |
| CAH Cardinal Health | Maintains: Market Perform | $59 → $72 | $154.44 | -53.38% | 1 | Aug 16, 2022 | |
| OTRK Ontrak | Downgrades: Underperform | $3,150 → $810 | $1.47 | +55,002.04% | 2 | Aug 20, 2021 | |
| TDOC Teladoc Health | Maintains: Outperform | $240 → $188 | $6.92 | +2,616.76% | 1 | Aug 9, 2021 | |
| OSCR Oscar Health | Initiates: Market Perform | $29 | $13.80 | +110.14% | 1 | Mar 29, 2021 |
CVS Health
Nov 25, 2024
Maintains: Buy
Price Target: $73 → $80
Current: $64.04
Upside: +24.92%
Walgreens Boots Alliance
Oct 22, 2024
Maintains: Buy
Price Target: $16 → $14
Current: $11.25
Upside: +24.44%
McKesson
May 8, 2024
Maintains: Buy
Price Target: $563 → $652
Current: $719.51
Upside: -9.38%
Chevron
Feb 24, 2023
Maintains: Outperform
Price Target: $185 → $170
Current: $136.70
Upside: +24.36%
Evolent Health
Jan 30, 2023
Maintains: Outperform
Price Target: $57 → $59
Current: $7.45
Upside: +691.95%
Cardinal Health
Aug 16, 2022
Maintains: Market Perform
Price Target: $59 → $72
Current: $154.44
Upside: -53.38%
Ontrak
Aug 20, 2021
Downgrades: Underperform
Price Target: $3,150 → $810
Current: $1.47
Upside: +55,002.04%
Teladoc Health
Aug 9, 2021
Maintains: Outperform
Price Target: $240 → $188
Current: $6.92
Upside: +2,616.76%
Oscar Health
Mar 29, 2021
Initiates: Market Perform
Price Target: $29
Current: $13.80
Upside: +110.14%